Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

MURAL HEALTH

Filed by TROUTMAN STRATEGIES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-04 06:26:19 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 15, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
35f43610-8412-4129-846e-53f276716c0a
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MED · Medical/Disease Research/Clinical Labs

Issues related to taxing payments and reimbursements to participants in clinical trials. H. R. 4184/S.5127 To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.

Literal federal measure citations: H. R. 4184, S.5127

HCR · Health Issues

Issues related to taxing payments and reimbursements to participants in clinical trials. H. R. 4184/S.5127 To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.

Literal federal measure citations: H. R. 4184, S.5127

TAX · Taxation/Internal Revenue Code

Issues related to taxing payments and reimbursements to participants in clinical trials. H. R. 4184/S.5127 To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.

Literal federal measure citations: H. R. 4184, S.5127

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.